<?xml version="1.0" encoding="UTF-8"?>
<p>We identified 13 guidelines that were evidence-based, peer reviewed, and either national or international. According to the Appraisal of Guidelines Research and Evaluation II, each guideline was reviewed by 2 committee members for academic integrity and applicability to actual clinical practice. During the development of the current guideline, the 2015 Korean Association for the Study of the Liver (KASL) hepatitis B guidelines were updated as the 2018 KASL hepatitis B guidelines, and we adapted the updated guideline. Finally, all the 13 highly qualified guidelines (
 <xref rid="t1-ir-2019-09155" ref-type="table">Table 1</xref>) [
 <xref rid="b2-ir-2019-09155" ref-type="bibr">2</xref>,
 <xref rid="b5-ir-2019-09155" ref-type="bibr">5</xref>-
 <xref rid="b16-ir-2019-09155" ref-type="bibr">16</xref>] were selected, analyzed, and summarized in terms of their evidence and medical recommendations relevant to our guideline.
</p>
